Literature DB >> 14734705

Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network.

Terry S Field1, Jackie Cernieux, Diana Buist, Ann Geiger, Lois Lamerato, Gene Hart, Don Bachman, Rick Krajenta, Sarah Greene, Mark C Hornbrook, Gary Ansell, Lisa Herrinton, George Reed.   

Abstract

Population laboratories with complete clinical information on episodes of care are needed to support research on the quality of care delivered to cancer patients. Data resources within the Cancer Research Network (CRN) may overcome many of the limitations of existing cancer databases, but their potential clinical value depends on the stability of the enrolled population. To assess this issue, we studied the retention rates among survivors of the 132 580 patients diagnosed with cancer from January 1, 1993, through December 31, 1998, who were enrolled at five health maintenance organization sites participating in the CRN. Enrollees were followed from cancer diagnosis through death, disenrollment, or the end of follow-up (i.e., December 31, 1999). The retention rate among survivors for all cancers combined at 1 and 5 years after cancer diagnosis was 96.0% (95% confidence interval [CI] = 95.9% to 96.1%) and 83.9% (95% CI = 83.4% to 84.3%), respectively. The proportion of enrollees diagnosed with cancer who remained enrolled and available for evaluation suggests that the CRN is well-suited for studies of the quality of care for cancer patients, survivorship, and long-term outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 14734705     DOI: 10.1093/jnci/djh010

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Authors:  Diana S M Buist; Rod Walker; Erin J Aiello Bowles; Patricia A Carney; Stephen H Taplin; Tracy Onega; Karla Kerlikowske; Walter Clinton; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-01       Impact factor: 4.254

2.  Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Authors:  Daniel M Frendl; Mara M Epstein; Hassan Fouayzi; Richard Krajenta; Benjamin A Rybicki; Mitchell H Sokoloff
Journal:  Cancer Causes Control       Date:  2020-06-17       Impact factor: 2.506

3.  The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.

Authors:  Jessica Chubak; Rebecca Ziebell; Robert T Greenlee; Stacey Honda; Mark C Hornbrook; Mara Epstein; Larissa Nekhlyudov; Pamala A Pawloski; Debra P Ritzwoller; Nirupa R Ghai; Heather Spencer Feigelson; Heather A Clancy; V Paul Doria-Rose; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2016-09-17       Impact factor: 2.506

4.  Statin use and risk of multiple myeloma: An analysis from the cancer research network.

Authors:  Mara M Epstein; George Divine; Chun R Chao; Karen E Wells; Heather Spencer Feigelson; Delia Scholes; Douglas Roblin; Marianne Ulcickas Yood; Lawrence S Engel; Andrew Taylor; Joan Fortuny; Laurel A Habel; Christine C Johnson
Journal:  Int J Cancer       Date:  2017-05-15       Impact factor: 7.396

Review 5.  Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research.

Authors:  Larissa Nekhlyudov; Sarah M Greene; Jessica Chubak; Borsika Rabin; Leah Tuzzio; Sharon Rolnick; Terry S Field
Journal:  J Cancer Surviv       Date:  2012-12-14       Impact factor: 4.442

6.  Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.

Authors:  Sheila Weinmann; Andrew E Williams; Aruna Kamineni; Diana S M Buist; Erin E Masterson; Natasha K Stout; Azadeh Stark; Tyler R Ross; Christopher L Owens; Terry S Field; Chyke A Doubeni
Journal:  Cancer       Date:  2015-05-18       Impact factor: 6.860

7.  Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.

Authors:  Larissa Nekhlyudov; Laurel A Habel; Ninah Achacoso; Inkyung Jung; Reina Haque; Laura C Collins; Stuart J Schnitt; Charles P Quesenberry; Suzanne W Fletcher
Journal:  J Natl Cancer Inst       Date:  2012-04-05       Impact factor: 13.506

8.  Managed care and cancer outcomes for Medicare beneficiaries with disabilities.

Authors:  Richard G Roetzheim; Thomas N Chirikos; Kristen J Wells; Ellen P McCarthy; Long H Ngo; Donglin Li; Reed E Drews; Lisa I Iezzoni
Journal:  Am J Manag Care       Date:  2008-05       Impact factor: 2.229

9.  Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.

Authors:  Elena B Elkin; Nicole Ishill; Gerald F Riley; Peter B Bach; Mithat Gonen; Colin B Begg; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

10.  The Role of Research in Integrated Health Care Systems: The HMO Research Network.

Authors:  Thomas M Vogt; Jennifer Elston Lafata; Dennis D Tolsma; Sarah M Greene
Journal:  Perm J       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.